Statistics

Total Visits

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup7

Select a period of time:

Number of views in the range

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup4

Views

Views
November 20230
December 20230
January 20241
February 20240
March 20242
April 20241
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Germany1
 

Top cities views

Views
Ashburn1
Boardman1
Hanover1